Validae Health, L.P.

Short Hills, New Jersey, United States


Purpose

To develop a deployable, long-acting GLP-2 therapeutic delivered via patch to improve gut function, nutrient absorption, and oral vaccine response in infants, children and adult affected by environmental enteric dysfunction in LMICs.

Division

Global Health

Date

June 2026

Region Served

GLOBAL

Committed amount

$3,302,000

Grant topic

Discovery and Translational Sciences, Enterics, Diagnostics, Genomics & Epidemiology

Duration (months)

12

Grantee location

Short Hills, New Jersey, United States

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.